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Multiphasic Perfusion CT in Acute Middle
Cerebral Artery Ischemic Stroke:
Prediction of Final Infarct Volume and
Correlation with Clinical Outcome
Objective: To assess the utility of multiphasic perfusion CT in the prediction of
final infarct volume, and the relationship between lesion volume revealed by CT
imaging and clinical outcome in acute ischemic stroke patients who have not
undergone thrombolytic therapy.
Materials and Methods: Thirty-five patients underwent multiphasic perfusion
CT within six hours of stroke onset. After baseline unenhanced helical CT scan-
ning, contrast-enhanced CT scans were obtained 20, 34, 48, and 62 secs after
the injection of 90 mL contrast medium at a rate of 3 mL/sec. CT peak and total
perfusion maps were obtained from serial CT images, and the initial lesion vol-
umes revealed by CT were compared with final infarct volumes and clinical
scores. 
Results: Overall, the lesion volumes seen on CT peak perfusion maps correlat-
ed most strongly with final infarct volumes (R
2=0.819, p<0.001, slope of regres-
sion line=1.016), but individual data showed that they were less than final infarct
volume in 31.4% of patients. In those who showed early clinical improvement
(n=6), final infarct volume tended to be overestimated by CT peak perfusion map-
ping and only on total perfusion maps was there significant correlation between
lesion volume and final infarct volume (R
2=0.854, p=0.008). The lesion volumes
depicted by CT maps showed moderate correlation with baseline clinical scores
and clinical outcomes (R=0.445 0.706, p 0.007). 
Conclusion: CT peak perfusion maps demonstrate strong correlation between
lesion volume and final infarct volume, and accurately predict final infarct volume
in about two-thirds of the 35 patients. The lesion volume seen on CT maps shows
moderate correlation with clinical outcome.
ne of the essential roles of stroke imaging is to reveal the ischemic
penumbra that is the target of thrombolytic therapy. For optimal qualita-
tive assessment of reversible ischemic tissue (ischemic penumbra), stroke
imaging should be able to accurately predict the extent of final infarct volume, and ini-
tial images should depict the extent of irreversible damage. 
Even though perfusion MR imaging has been more widely used, helical CT tech-
niques providing coverage of all or most of the brain have recently been employed for
perfusion CT imaging, demonstrating their potential utility in the detection of arterial
occlusion, the assessment of cerebral perfusion, and the prediction of final infarct vol-
ume and clinical outcome (1 8). Although perfusion CT offers faster scanning, a
greater availability of scanners, and relatively easier data processing than perfusion
MR imaging, existing clinical data pertaining to the utility of perfusion CT in the pre-
diction of final infarction, and clinical symptoms and outcomes, are limited. A recent
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Ostudy (8) of patients who underwent intraarterial throm-
bolytic therapy suggested that the mismatch between un-
enhanced and perfusion-weighted CT lesion volumes might
reflect ischemic penumbra. To establish the role of perfu-
sion CT in guiding thrombolytic therapy beyond unen-
hanced CT scanning in acute ischemic stroke, further stud-
ies may be required. 
The most appropriate method for the imaging of is-
chemic penumbra has not yet been fully established, and
difficulty in this regard is also encountered at MR imaging
in acute ischemic stroke. Though it has been assumed that
the mismatch between diffusion-weighted and perfusion
MR imaging is due to ischemic penumbra, a hyperintense
or decreased ADC lesion, seen at diffusion-weighted imag-
ing, contains reversible ischemic tissue (9, 10), and in pa-
tients with proximal arterial occlusion, lesions which
demonstrate perfusion abnormality at qualitative perfusion
MR imaging may include an oligemic area as well as is-
chemic penumbra (11 14). 
For the assessment of patients with acute ischemic
stroke, we used a modified multiphasic perfusion CT pro-
tocol based on a triphasic helical CT technique (4), retro-
spectively evaluating multiphasic perfusion CT images and
testing the a hypothesis that in patients with acute middle
cerebral artery (MCA) stroke who have not undergone
thrombolytic therapy, multiphasic perfusion CT is predic-
tive of final infarct volume, baseline clinical score, and clin-
ical outcome. 
MATERIALS AND METHODS
Patients
Thirty-five consecutive patients [29 men, 17 women; age
range, 31-88 (mean, 64) years] who experienced MCA ter-
ritory stroke symptoms between October 1998 and
January 2001 were enrolled in this study. Informed con-
sent was obtained from each patient or their family before
CT imaging, and the study protocol was approved by our
institution’s review board.
Inclusion criteria were: (a) symptom onset, as identified
by the patient or other person, was less than six hours be-
fore CT scanning; (b) the National Institutes of Health
Stroke Scale (NIHSS) score was 4 or more; (c) unenhanced
CT revealed no hemorrhage; (d) post-CT treatment did not
include thrombolytic therapy or the use of a neuroprotec-
tive agent; (e) follow-up unenhanced CT or MR images
were obtained within 2-10 days of initial CT studies, and
were regarded as indicative of final infarct volume. 
Multiphasic Perfusion CT Imaging
Multiphasic perfusion CT images were obtained using a
helical CT scanner (High-speed Advantage; GE Medical
Systems, Milwaukee, Wis., U.S.A.) according to a modified
protocol based on a triphasic helical CT technique (4).
Following the acquisition of baseline conventional unen-
hanced CT images of the whole brain, contrast-enhanced
scans of eight slice sections were acquired five times at
each of four phases (20, 34, 48, and 62 secs) after the pow-
er injection of 90 mL non-ionic contrast agent at a rate of 3
mL/sec. Except for the lower portion of the posterior fossa
and vertex, CT scans covered most of the brain. All unen-
hanced and enhanced CT images were obtained at 10-mm
collimation and 10-mm/sec table speed, and were recon-
structed at 5-mm intervals. The scanning parameters were
120 kilovolts and 240 mA (conventional unenhanced CT)
or 200 mA (helical CT), with a 512 512 image matrix
and a 23-cm field of view. 
From the serial images obtained during the five phases,
two CT perfusion maps were retrospectively generated.
Prior to data processing for CT mapping of all patients,
possible head movement was corrected, using the semiau-
tomated registration technique (15). Bony calvarium only,
rather than whole brain pixels, was coregistered, and the
time required for this process was thus shortened. First, a
peak perfusion CT map was generated on a pixel-by-pixel
basis by simple subtraction of registered, baseline, unen-
hanced helical CT images from the enhanced images ob-
tained during peak enhancement of the contralateral hemi-
sphere. In the resultant images, voxel intensity is produced
by a change in Hounsfield units ( HU) proportional to the
concentration of contrast agent within a voxel of tissue.
Second, a total perfusion CT map was generated on a pix-
el-by-pixel basis after calculating the area under the time-
attenuation curve by subtracting unenhanced helical CT
from contrast-enhanced CT images obtained during the
four phases of enhanced CT scanning. Two CT maps were
generated off-line at a personal computer workstation after
the transfer there of raw CT data. The total scanning time
for the completion of acquisitions and reconstruction of im-
ages was less than five minutes, and about five minutes
were required for the processing of CT map data.
Volumetric Measurement and Analysis
Quantitative analysis involved measurement of the le-
sion volumes seen at initial CT and follow-up MR or CT
imaging. After imaging data were transferred to a personal
computer, lesion volumes were measured using a commer-
cially available software program (ALICE; Hayden
Imaging Processing Solutions, Boulder, Col., U.S.A.).
Lesion volumes were measured manually by one rater
blinded, except for information as to which hemisphere
was affected, to the results of counterpart CT or MR imag-
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ume of each lesion was initially measured on each CT im-
age and then on follow-up images after at least 2 weeks.
After the area of a lesion was measured at each eight-slice
section, integration and multiplication of slice thickness
was used to calculate lesion volume. Before one rater mea-
sured this for each image, lesion outlines were visually de-
termined by two raters, who reached a consensus after re-
viewing the hypoattenuated parenchymal areas seen at
conventional unenhanced CT and areas of decreased densi-
ty on CT peak or total perfusion maps of multiphasic per-
fusion CT. At follow-up imaging, the lesion volume
demonstrated by fluid-attenuated inversion recovery MRI
(n=22) or unenhanced CT imaging (n=13) was determined.
Correlation between the initial lesion volume seen on
each CT image and final infarct volume at follow-up imag-
ing was analyzed overall and for each subgroup, and either
clinical improvement within 24 hours of symptom onset
(n=6), or later than this (n=29) was recorded. Mismatched
lesion volume between the findings of unenhanced CT and
CT peak perfusion maps was compared with the volume of
infarct growth determined as final infarct volume minus
initial lesion volume as seen at unenhanced CT.
For comparison of individual lesion volumes between
initial and follow-up images, and in view of possible errors
in manual measurements, a difference was considered sig-
nificant if greater than 20% of volume and more than 3
cm3. Measured lesion volumes at initial CT or as seen on
map images were compared with those obtained at follow-
up imaging, and the prediction of final infarct volume on
the basis of initial CT or MR imaging findings was catego-
rized as ‘overestimation’ (more than 120 % of the lesion
volume seen at follow-up imaging), ‘concordant’ (80%-
120%), or ‘underestimation’ (less than 80%). 
For each patient, NIHSS scores were recorded by experi-
enced neurologists at baseline, and 24 hours, 3 days, 7
days, and 1 month after onset of symptoms. Since they
were in many cases unavailable, an analysis of NIHSS
scores at 3 months was not included in this study. The le-
sion volumes seen at unenhanced CT, and on CT peak and
total perfusion maps were compared with clinical scores. 
Statistical Analysis
Using linear regression analysis, initial lesion volumes
were correlated with the final infarct volumes seen at fol-
low-up imaging. Pearson correlation coefficients and coef-
ficients of determination (R
2) were used to represent the re-
lationship between each lesion volume and to estimate the
proportion of variation in the dependent variable. To com-
pare the overall tendency of each lesion volume deter-
mined at CT imaging, the slope of regression line fitted by
a forced zero intercept were determined. To compare the
initial lesion volume seen at CT imaging with the NIHSS
score, Spearman’s rank correlation test was used. 
RESULTS
The mean period between symptom onset and multipha-
sic perfusion CT was 3.0 1.7 (range, 0.5 to 6) hours, and
the mean time interval before follow-up imaging was 4.8
2.6 (range, 2 to 10) days. 
Table 1 shows the relationship between initial lesion vol-
umes at CT imaging and follow-up infarct volumes; scatter-
plots of each data set are shown in Figure 1. Overall, there
was significant correlation between initial lesion volume
and final infarct volume, as seen at unenhanced CT and on
CT peak and total perfusion maps. The initial lesion vol-
ume seen on CT peak perfusion maps correlated most
strongly with final infarct volume measured at either fol-
low-up unenhanced CT or MRI (R
2=0.819, p<0.001) and
tended to be similar to final infarct volume (slope of re-
gression line, 1.016) (Fig. 2). Meanwhile, final infarct vol-
umes were significantly underestimated by total perfusion
mapping and unenhanced CT (slope of regression lines,
1.246 and 1.523, respectively), as demonstrated by Figure
3. The mismatch between lesion volume at unenhanced CT
and on CT peak perfusion maps correlated significantly
with the volume of infarct growth (R=0.756, R
2=0.572,
p<0.001), showing, overall, a mean value slightly less than
this (43.89 42.01 vs. 50.45 39.38, respectively) but
slightly more than final infarct volume (slope of regression
line=0.942). 
In the subgroup (n=6) which showed early spontaneous
improvement in the NIHSS score (> 4) at 24 hours after
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Table 1. Correlation between Lesion Volumes at Initial Multiphasic Perfusion CT and Follow-Up Imaging (n=35) 
CT or MR Imaging Lesion Volume (cm
3) Mean (Standard Deviation) Correlation Value R (R
2) p value
Unenhanced CT 37.45 (50.09) 0.801 (0.641) < 0.0001
CT peak perfusion map 81.35 (65.13) 0.905 (0.819) < 0.0001
CT total perfusion map 59.08 (58.82) 0.893 (0.797) < 0.0001
Follow-up with unenhanced CT or MRI 87.90 (65.61)
Note. Pearson correlation coefficient.symptom onset, initial lesion volumes on CT peak perfu-
sion maps were greater than final infarct volumes (30.73
24.67 vs. 16.71 20.37), though the difference was statisti-
cally insignificant (p=0.226). Meanwhile, in this subgroup,
the initial lesion volume seen on CT total perfusion maps
was 15.06 15.31 cm3, and final infarct volume correlated
strongly only with the lesion volumes on CT total perfu-
sion maps (R2=0.854, p=0.008). In the subgroup (n=29)
which showed no early clinical improvement, final infarct
volumes were slightly underestimated on CT peak perfu-
sion maps (R2=0.819, p<0.001, slope of regression
line=1.027), and more significantly underestimated on to-
tal perfusion maps (R2=0.785, p<0.001, slope of regression
line=1.247).  
The results of analysis of individual data are shown in
Table 2. Although there is linearity between the initial le-
sion volumes seen on peak perfusion maps and final infarct
volumes, the latter were underestimated in 11 (31.4%) pa-
tients and severely underestimated as less than 50% of ac-
tual final infarct volume in five (14.3%). Final infarct vol-
umes were underestimated on CT total perfusion maps and
at unenhanced CT in 68.5% and 85.7% of cases, respec-
tively. 
Table 3 shows the relationship between initial lesion vol-
ume at CT and NIHSS score. Correlation between initial
lesion volume at unenhanced CT and baseline NIHSS score
or clinical outcome converted into follow-up NIHSS score
at days 3, 7 and 30 was only modest (R=0.362 0.482),
while that between initial lesion volume at CT peak or to-
tal perfusion mapping and baseline NIHSS score or clinical
outcome (R=0.445 0.706) was moderate. Between peak
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Fig. 1. Overall correlation between initial lesion volume and final
infarct at unenhanced CT, and on CT peak and total perfusion
maps. The relationship between initial lesion and final infarct vol-
ume was strongest on CT peak perfusion maps (R
2=0.819), fol-
lowed by CT total perfusion maps (R
2=0.797) and unenhanced
CT (R
2=0.641). CT peak perfusion maps showed that initial lesion
volume was slightly less than final infarct volume (slope of regres-
sion line=1.016), while CT total perfusion maps and unenhanced
CT showed it as significantly less (slope of regression line=1.246
and 1.523, respectively). 
Table 2. Prediction of Final Infarct Volume by Initial Unenhanced CT, and Peak and Total Perfusion CT Mapping
Degree of Prediction
Percentage of  Multiphasic Perfusion CT
Lesion Volume Unenhanced CT Peak Perfusion  Total Perfusion 
Overestimation > 120 00 0(0) 03 0(8.6)  01 0(2.9) 
Concordant 80 120 05 (14.3) 21 (60.0) 10 (28.6)
Underestimation 30 (85.7) 11 (31.4) 24 (68.6)
Mild 50 080 09 061 6
Severe < 50 21 05 08
Note. Numbers in parentheses are percentages, *Percentage of lesion volume = lesion volume at initial CT imaging / lesion volume at follow-up imaging
100
Table 3. Correlation of Initial Lesion Volumes at Multiphasic Perfusion CT with National Institutes of Health Stroke Scale Scores 
CT or MR Imaging Correlation Value, R (p Value) with NIHSS Scores
Baseline (n=35) 3 days (n=34) 7 days (n=32) 30 days (n=28)
Unenhanced CT 0.362 (0.033) 0.482 < (0.005) 0.455 < (0.009) 0.421 < (0.026)
CT peak perfusion map 0.533 (0.001) 0.706 (< 0.001) 0.654 (< 0.001) 0.548 < (0.003)
CT total perfusion Map 0.445 (0.007) 0.665 (< 0.001) 0.649 (< 0.001) 0.554 < (0.002)
Follow-up CT or MRI 0.481 (0.003) 0.787 (< 0.001) 0.750 (< 0.001) 0.677 (< 0.001)
Note. NIHSS = National Institutes of Health Stroke Scale,  Spearman’s correlation coefficient or total perfusion mapping and clinical outcome, correla-
tion was relatively stronger at the acute or subacute stage
(3 or 7 days) than at the chronic stage (30 days). The rela-
tionship between baseline NIHSS score and final infarct
volume at follow-up unenhanced CT or MRI was similar to
that between this score and the volume seen at initial CT
peak or total perfusion mapping, but clinical outcomes con-
verted into follow-up NIHSS score at days 3, 7, and 30
showed slightly stronger correlation with final rather than
initial infarct volume. 
DISCUSSION
Because the contrast agent used is continuously injected
for 30 seconds, the multiphasic perfusion CT technique
does not permit a first pass of contrast agent. Instead, a rel-
atively constant period of peak tissue enhancement is
maintained. During this period of peak enhancement, the
concentration of contrast agent in intravascular tissue space
within a voxel is fairly constant (4), and the CT peak de-
picted by a perfusion map may be an image of cerebral
perfusion determined by cerebral blood volume and cere-
bral blood flow (3). If delivery of the contrast agent is sig-
nificantly delayed by low cerebral blood flow in any area,
peak perfusion maps will demonstrate low intensity in that
area, even though cerebral blood volume is, in fact, high,
and this may explain the mismatch between CT peak and
total perfusion maps (Fig. 3). 
A CT total perfusion map obtained by integration of the
area under a time-attenuation curve depicts the total per-
fused blood volume in a voxel within the period of scan-
ning. On a map of this kind, some areas of a hypoperfused
lesion seen on a CT peak perfusion map appear to be nor-
mal (Fig. 3), suggesting that while a peak perfusion map
depicts perfused blood volume due to rapid effective col-
lateral flow, a total perfusion map depicts the total per-
fused volume of both slow and rapid collateral flow. Thus,
it may be speculated that if a lesion appears on both total
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Fig. 2. Correspondence between lesion
volume at CT peak perfusion mapping
and final infarct volume in a 31-year-old
female who underwent multiphasic per-
fusion CT five hours after the onset of
stroke symptoms. Unenhanced CT (A)
shows diffuse parenchymal hypodensity
and loss of cortex/white matter distinc-
tion (arrows) in left MCA territory. Lesion
size at unenhanced CT is similar to that
of the hypoperfused lesion (arrows)
seen on CT peak (B) and total perfusion
maps (C), indicating no mismatch be-
tween these two maps or between un-
enhanced CT and CT maps. Follow-up
CT images (D) obtained 3 days after ini-
tial CT show a significant mass effect
and infarction edema in the left hemi-
sphere. Seven days after the onset of
stroke, the NIHSS score was slightly ag-
gravated (increase of 4). 
AB
CDand peak perfusion maps, conversion to infarction will be
more rapid and there will be more significant vasogenic
edema (Fig. 2) than where a lesion appears only on a peak
perfusion map (Fig. 3). By reference to peak and total per-
fusion maps of multiphasic perfusion CT, both the degree
of hypoperfusion in tissue and the extent of infarction may
be qualitatively predicted. 
If imaging is used for the qualitative assessment of cere-
bral ischemia, the extent of infarct growth, determined ac-
cording to the difference between final infarct volume at
follow-up and the volume of irreversibly damaged tissue
seen at initial imaging, may be considered indicative of the
extent of ischemic penumbra. Our data for untreated pa-
tients showed that on peak perfusion maps, lesion volume
was equal to or less than that of the final infarct in 91.5%
of patients, suggesting that if early arterial recanalization
does not occur, a hypoperfused lesion seen on a CT peak
perfusion map is, at follow up, highly specific for infarc-
tion. Our data also suggest that with regard to lesion vol-
ume, the observed mismatch between a CT peak perfusion
map and unenhanced CT is predictive of the extent of in-
farct growth. The mismatched volume was, however,
slightly smaller than the volume of infarct growth, and
there was only moderate correlation between initial lesion
volume at CT peak perfusion mapping and baseline clinical
scores. Thus, the mismatch between a CT peak perfusion
map and unenhanced CT may underestimate the true ex-
tent of ischemic penumbra. The parenchymal hypodensity
seen at unenhanced CT is known to be highly specific for
irreversible ischemic tissue (16), but whether this hypoden-
Yi et al.
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Fig. 3. Overestimation of lesion volume
on CT peak perfusion map in a 75-year-
old female who underwent multiphasic
perfusion CT 2 1/2 hours after the onset
of stroke symptoms. Unenhanced CT
(A) reveals no parenchymal hypodensi-
ty. The CT peak perfusion map (B),
though not the total perfusion map (C),
depicts a diffuse hypoperfused lesion
(arrows) in left MCA territory, suggesting
abundant delayed collateral flow. This
case shows significant mismatch be-
tween the CT peak perfusion map and
unenhanced CT, as well as between CT
peak perfusion and total perfusion
maps. Follow-up CT (D) performed two
days after initial CT, shows little mass
effect of the ischemic lesion and a small-
er infarction than the  hypoperfused le-
sion seen on the CT peak perfusion
map. Seven days after the onset of
stroke, the NIHSS score showed no sig-
nificant change (decrease of 1). 
AB
CDsity accurately represents the extent of such damage has
not been definitely established. Although CT peak perfu-
sion maps and unenhanced CT may, respectively, tend to
underestimate final infarct volume and the extent of irre-
versible tissue damage, we suggest that ischemic penumbra
may be approximately estimated by the extent of mis-
match between a hypoperfused lesion seen at CT peak per-
fusion mapping and a slightly and low attenuated lesion
seen at unenhanced CT. 
Our data showed that baseline clinical score correlated
more closely with lesion volume at CT peak or total perfu-
sion mapping than with lesion volume at unenhanced CT,
which is associated with the severity of clinical symptoms.
Patel et al. (17) reported that initial lesion volume at unen-
hanced CT correlated with baseline NIHSS score and a fa-
vorable outcome at three months, and Mark et al. (18) stat-
ed that at unenhanced CT, a larger lesion was associated
with a higher baseline NIHSS score. The stronger relation-
ship between lesion volume, as revealed by CT peak per-
fusion mapping, and baseline clinical score suggests that
prior to tissue change, as cerebral blood flow decreases be-
low a threshold of cortical dysfunction (20 mL/100 g/min),
a hypoperfused lesion seen at CT peak perfusion mapping
has a closer relationship with the area of cortical dysfunc-
tion. The observed significant correlation between lesion
volume at CT total perfusion mapping and baseline clinical
score also suggests that severe hypoperfusion is associated
with the severity of clinical symptoms. Although correla-
tion between lesion volume on a CT peak or total perfu-
sion map and baseline or acute clinical scores was only
moderate, CT maps appear no less predictive of the severi-
ty of clinical symptoms than diffusion or perfusion MR
imaging. Recent studies (11, 19 21) of stroke MR imaging
showed that for various relationships between the acute
NIHSS score and lesion volume at diffusion-weighted
(r=0.31 0.71) or qualitative perfusion MR imaging
(r=0.31 0.96), the data was inconsistent. 
It may be speculated that because a large mismatch at
multiphasic perfusion CT suggests the possible presence of
extensive ischemic penumbra, salvageable by early re-
canalization, thrombolytic therapy may be of more benefit
to patients whose lesion findings show a mismatch be-
tween CT peak perfusion mapping and unenhanced CT,
than those with no mismatch. In patients with hyperacute
ischemic stroke, a mismatch between unenhanced CT and
peak perfusion mapping, seen at on multiphasic perfusion
CT, might be able to provide useful information for the
guidance of thrombolytic therapy. To determine the clini-
cal value of mismatch at multiphasic perfusion CT, further
investigation is needed, and our study involving acute is-
chemic stroke patients who have undergone thrombolytic
therapy is, in fact, in progress. 
The drawbacks of our CT method include the noisy im-
age quality of CT maps, the possibility of contrast agent-in-
duced complications, and a lack of quantitative informa-
tion about cerebral perfusion. A small ischemic lesion may
not be detected at peak perfusion CT mapping, and be-
cause the perfusion of white matter is relatively low (less
than half that of gray matter), a mildly hypoperfused white
matter lesion may not be apparent on CT maps. Because,
in most patients, follow-up scans were obtained during
acute-stage ischemia, the size of a lesion thus depicted may
not correspond to the true size of the infarct; this may in
some cases be overestimated due to brain edema or
swelling (22), or underestimated because the infarct contin-
ues to grow (23). 
In conclusion, initial lesion volume at CT peak perfusion
mapping showed strong correlation with final infarct vol-
ume, was highly specific for final infarction, and accurately
predicted final infarct volume in about two-thirds of the 35
patients. A mismatch between lesion volume at CT peak or
total perfusion mapping and at unenhanced CT was predic-
tive of lesion growth. Clinical outcome correlated more
strongly, though still only moderately, with lesion volume
at CT peak or total perfusion mapping than with lesion
volume at unenhanced CT. Multiphasic perfusion CT is
useful for prediction of the initial severity of clinical symp-
toms, the extent of final infarction, and clinical outcomes. 
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